Likewise, our partial transcriptomic analysis using NanoString revealed that Trem2−/− mice injected with AD-tau maintain the expression of genes previously identified as contributors to the detrimental effects of tau or which are involved in microglial activation, similar to control mice. This evidence concerns the gene MAPT and Alzheimer disease.